Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 18 results for "daiichi sankyo"

Daiichi case: HC asks Singh bros to declare value of total stake

In the long drawn court battle between Japanese drugmaker Daiichi Sankyo and the former Ranbaxy promoters Malvinder and Shivinder Singh, the Delhi High Court today ordered the Singh brothers to declare the value of their debt free shareholdings in various ... Money Control, 4 weeks ago

44 images for daiichi sankyo

PharmaVOICE, 1 month ago
VC Circle, 1 month ago
Financial Express, 1 month ago
Nasdaq, 2 weeks ago
Pharma Live, 1 month ago
Livemint.com, 1 month ago
Money Today, 1 month ago
PharmaVOICE, 2 months ago
Pharmaceutical Tech.com, 1 month ago
Financial Express, 1 month ago

No stay on Fortis stake sale plan yet

Daiichi Sankyo had sought a stay on plans by Malvinder and Shivinder Singh to sell over 26% in the healthcare firm New Delhi, January 17: The battle between the Singh brothers of Fortis and Japanese pharma company Daiichi Sankyo has reached a stalemate for ...
 Business Line1 month ago Daiichi Sankyo opposes Fortis Health stake sale, moves Delhi HC  Money Control1 month ago

Daiichi Sankyo says Sayonara to India; terminates contract of 170 employees

The company's closure of R&D establishment in Gurgaon marks its exit from Indian market
 Business Standard1 month ago Daiichi to shut down Indian RD centre; 170 employees impacted  Money Control1 month ago
Money Today

Daiichi-Singh brothers feud: More about arbitration, than about compensation

Delhi High Court is hearing a plea from Japanese drug major Daiichi Sankyo, to prevent the erstwhile promoters of Ranbaxy pharmaceuticals - brothers Malvinder Mohan Singh and Shivinder Mohan Singh - from diluting their stake in Fortis Healthcare. Daiichi's ...
 Money Today1 month ago Fortis stake sale: Delhi HC to hear Daiichi plea on Jan 23  Money Control1 month ago

Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

E Kumar Sharma New Delhi Last Updated: January 18, 2017 | 16:43 IST On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its research subsidiary, Daiichi Sankyo India Pharma ...
 Money Today1 month ago
Business Standard

Lupin receives US FDA nod for generic Evoxac capsule

Evoxac capsule, marketed by Daiichi Sankyo, had recorded sales of $ 40.8 million in the US January 3, 2017 Last Updated at 10:15 IST RECOMMENDED FOR YOU Subscribe to the Business Standard b2b Connect Newsletters and stay updated with latest news, features, ...
 Business Standard1 month ago Lupin receives FDA nod for generic Evoxac Capsules  India Infoline1 month ago

Kite Pharma partners with Japan's Daiichi for cancer therapy

Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments. The company will also receive low to mid ...
 Reuters1 month ago

Sensex Ends Dull on First Trading Day of 2017; Realty Index Surges 4.3%

Posted by Equitymaster The Indian share markets started the new year's trading day on a dull note. At the closing bell, the BSE Sensex closed lower by 31 points, whereas the NSE Nifty finished lower by 6 points. The S&P BSE Midcap ended up by 0.8% while the ...
 Equitymaster.com1 month ago

Sensex Opens Flat; IT & Pharma Stocks Top Gainers

Posted by Equitymaster Asian markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.03% while the Hang Seng is down 0.09%. The Shanghai Composite is trading down by 0.28%. Stock markets in the US and Europe closed their ...
 Equitymaster.com1 month ago
India Infoline

Lupin gets tentative approval for generic Benicar tablets; stocks up 1%

line News Service | Mumbai | December 26, 2016 11:15 IST Lupin’s Olmesartan Medoximil tablets 5mg, 20 mg and 40 mg are the AB rated generic equivalents of Daiichi Sankyo Inc’s Benicar tablets, 5 mg, 20 mg and 40 mg.
 India Infoline1 month ago Lupin receives tentative approval for generic Benicar tablets  Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less